Emergent Biosolutions Inc (EBS)

Net Debt

$442.10M

Quarterly · Period ending: · USD

EBS logo

EBS Net Debt

Latest reported$442.10M
EBS Quarterly Net Debt ($314.70M → $442.10M)
High-resolution chart · PNG

EBS net debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Net Debt — Quarterly (USD)
Period endingNet Debt (USD)
442,100,000
413,300,000
366,700,000
417,600,000
405,100,000
516,600,000
570,500,000
526,100,000
807,100,000
843,200,000
765,800,000
792,100,000
831,300,000
984,600,000
783,800,000
833,800,000
467,100,000
425,700,000
294,700,000
475,100,000
437,900,000
342,700,000
301,700,000
505,800,000
544,300,000
634,400,000
668,900,000
684,200,000
663,100,000
605,300,000
682,400,000
-325,863,000
-176,755,000
-150,137,000
-164,835,000
-91,997,000
-66,934,000
-21,776,000
-3,419,000
-31,139,000
-86,002,000
-93,824,000
-59,795,000
-55,718,000
38,159,000
34,485,000
-29,499,000
8,751,000
82,870,000
90,785,000
-117,338,000
-113,139,000
-95,704,000
-68,581,000
-78,892,000
-134,887,000
-99,646,000
-89,553,000
-84,447,000
-71,553,000
-82,791,000
-90,341,000
-121,593,000
-102,966,000
-53,097,000
-51,422,000
-37,206,000
-79,190,000
-46,950,000
-4,856,000
-34,290,000
-46,298,000
-24,695,000
-32,521,000
-47,796,000
22,707,000
-1,363,000
-34,261,000
-33,647,000
16,567,000
-24,384,000
6,046,000
-544,500,000
314,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.